BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10214866)

  • 1. In vivo and in vitro effects of cytokines and the hemoregulatory peptide dimer (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 on G alpha16-positive hematopoiesis.
    Pfeilstöcker M; Karlic H; Paukovits J; Anzenberger G; Louda N; Salamon J; Mühlberger H; Strobl H; Pittermann E; Heinz R
    Leukemia; 1999 Apr; 13(4):590-4. PubMed ID: 10214866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
    Karlic H; Louda N; Pfeilstöcker M; Keil F; Lohninger A; Pittermann E; Paukovits J
    Stem Cells; 2001; 19(4):321-8. PubMed ID: 11463952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of hematopoietic recovery after autologous stem cell transplantation by analysis of G alpha 16 mRNA and CD34 surface glycoprotein.
    Pfeilstöcker M; Karlic H; Salamon J; Mühlberger H; Pavlova B; Selim U; Strobl H; Pittermann E; Heinz R
    Ann Hematol; 1998; 76(3-4):153-8. PubMed ID: 9619733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys: a new synthetic derivative for avoiding dimerization and loss of inhibitory activity.
    Paukovits WR; Hergl A; Schulte-Hermann R
    Mol Pharmacol; 1990 Sep; 38(3):401-9. PubMed ID: 2402229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hemoregulatory peptide pEEDCK may inhibit stem cell proliferation via hydropathic binding to antisense sequence motifs in interleukin-11 and other growth factors.
    Paukovits JB; Rutter R; Ganglberger E; Karlic HI; Marian B; Paukovits WR
    Mol Pharmacol; 1999 Oct; 56(4):665-74. PubMed ID: 10496948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic recovery after IEV chemotherapy for malignant lymphoma followed by different cytokines can be monitored by analysis of Galpha 16 and CD34.
    Pfeilstöcker M; Karlic H; Salamon J; Mühlberger H; Pavlova B; Strobl H; Pittermann E; Heinz R
    Am J Hematol; 2000 Jul; 64(3):156-60. PubMed ID: 10861809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated granulocytes oxidize the endogenous stem cell inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK) to the stimulatory dimer: a redox-mediated mechanism for demand-induced hematopoietic regulation.
    Paukovits WR; Paukovits JB; Moser MH; Konstantinov S; Schulte-Hermann R
    Exp Hematol; 1998 Aug; 26(9):851-8. PubMed ID: 9694506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hematopoietic stem cell proliferation by hemoregulatory peptide pyroGlu-Glu-Asp-Cys-Lys (pEEDCK) provides protection against short-term neutropenia and long-term damage.
    Paukovits WR; Moser MH; Rutter R; Paukovits JB
    Ann N Y Acad Sci; 1991; 628():92-104. PubMed ID: 2069326
    [No Abstract]   [Full Text] [Related]  

  • 9. Protection from arabinofuranosylcytosine and n-mustard-induced myelotoxicity using hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys monomer and dimer.
    Paukovits WR; Moser MH; Binder KA; Paukovits JB
    Blood; 1991 Mar; 77(6):1313-9. PubMed ID: 2001454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of G alpha 16, a G-protein alpha subunit specific for hematopoiesis in acute leukemia.
    Pfeilstöcker M; Karlic H; Salamon J; Krömer E; Mühlberger H; Pavlova B; Selim U; Tüchler H; Fritsch G; Kneissl S; Heinz R; Pitterman E; Paukovits MR
    Leukemia; 1996 Jul; 10(7):1117-21. PubMed ID: 8683989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of haemoregulatory peptides (pEEDCK monomer and dimer) for reduction of cytostatic drug induced haemopoietic damage.
    Paukovits WR; Moser MH; Binder KA; Paukovits JB
    Cancer Treat Rev; 1990 Sep; 17(2-3):347-54. PubMed ID: 2272050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sequence of the hemoregulatory peptide is present in Gi alpha proteins.
    Laerum OD; Frostad S; Tøn HI; Kamp D
    FEBS Lett; 1990 Aug; 269(1):11-4. PubMed ID: 2117550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal cell-independent differentiation of human cord blood CD34+CD38- lymphohematopoietic progenitors toward B cell lineage.
    Yoshikawa Y; Hirayama F; Kanai M; Nakajo S; Ohkawara J; Fujihara M; Yamaguchi M; Sato N; Kasai M; Sekiguchi S; Ikebuchi K
    Leukemia; 2000 Apr; 14(4):727-34. PubMed ID: 10764162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
    Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-CFU-S quiescence and stem cell exhaustion after cytostatic drug treatment: protective effects of the inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK).
    Paukovits WR; Moser MH; Paukovits JB
    Blood; 1993 Apr; 81(7):1755-61. PubMed ID: 8461461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential modulation of adhesion markers with ex vivo expansion of human umbilical CD34+ progenitor cells.
    Reems JA; Mielcarek M; Torok-Storb B
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):133-41. PubMed ID: 9310190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a cytokine combination including thrombopoietin for improved transduction of a retroviral gene into G-CSF-mobilized CD34+ human blood cells.
    Kim HJ; Okamoto Y; Ito M; Takaue Y; Kawano Y; Watanabe T; Yamaue T; Tohda Y; Ogose T; Shimada T; Shimosaka A; Kuroda Y
    Stem Cells; 1997; 15(5):347-52. PubMed ID: 9323796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell stimulation in vitro by the dekapeptide (pEEDCK)2: a single-factor alternative for multifactor cocktails.
    Paukovits JB; Paukovits WR
    Leukemia; 1995 Oct; 9 Suppl 1():S48-52. PubMed ID: 7475313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.